2020 Updates on Cell-Intrinsic Drivers in CLL: Does Ibrutinib Prolong PFS in Untreated Older Patients? How Do BCL2, BTK and PLCg2 Mutations Work as Mechanisms of Resistance?
Recorded by OpenAudience™.
Login to view comments.
Click here to Login